Free Trial

Canopy Growth (TSE:WEED) Trading Down 8.2% - Should You Sell?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) shares dropped 8.2% during trading on Friday . The company traded as low as C$2.46 and last traded at C$2.47. Approximately 1,199,201 shares were traded during mid-day trading, a decline of 28% from the average daily volume of 1,655,880 shares. The stock had previously closed at C$2.69.

Wall Street Analyst Weigh In

Several equities analysts have commented on WEED shares. ATB Capital dropped their price target on shares of Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating on the stock in a research note on Monday, February 10th. Canaccord Genuity Group dropped their target price on shares of Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating on the stock in a research report on Monday, February 10th. Four equities research analysts have rated the stock with a sell rating and one has assigned a hold rating to the stock. According to data from MarketBeat.com, Canopy Growth has a consensus rating of "Reduce" and an average price target of C$5.64.

Get Our Latest Research Report on Canopy Growth

Canopy Growth Price Performance

The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39. The company has a market capitalization of C$394.13 million, a PE ratio of -0.36, a P/E/G ratio of -0.01 and a beta of 1.79. The company's 50-day simple moving average is C$1.75 and its 200-day simple moving average is C$2.93.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Further Reading

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines